Tag: Benaroya Research Institute
Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...
Aimmune plans to submit a Biologics License Application for AR101 to the FDA by the end of 2018.
Institute Receives $5M Grant to Study Personalized Treatments for Peanut Allergy
What they discover could guide the design of a new strategy for immune intervention.
Th2A: the Key to Unlocking Better Testing and a Cure for...
A look at what all the excitement is about.
Adult Peanut Allergy: Therapy Cleared to Begin Phase IIa Trials
Antibody targets trigger also implicated in other food allergies, atopic diseases, and asthma.